Clinical Trial Update: Prolgolimab Monotherapy or in Combination With Bendamustine for r/r Classical Hodgkin Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating prologolimab as monotherapy or with bendamustine for relapsed/refractory classical Hodgkin lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma

Drugs mentioned

• Bendamustine (Bendamustine)
• prologolimab (prologolimab)

Snippet

Sponsor: St. Petersburg State Pavlov Medical University | Conditions: Hodgkin Lymphoma | Phase 2 | Status: UNKNOWN